Microcarriers Market Share, Size, Trends, Industry Analysis Report, By Product (Consumables, Equipment); By Application; By Therapy; By Region; Segment Forecast, 2024 - 2032
- Published Date:Feb-2024
- Pages: 117
- Format: PDF
- Report ID: PM4360
- Base Year: 2023
- Historical Data: 2019 – 2022
Report Outlook
The global microcarriers market size was valued at USD 1.56 billion in 2023 and is expected to grow at a CAGR of 11.4% during the forecast period.
Rising research activities on cell and gene therapy are driving new growth potential for the market in the coming years. In bioprocessing, one of the main factors for researchers is the production of higher volumes. According to the researchers from the University of Minnesota Medical School, with the microcarrier-based bioreactor, higher levels of human mesenchymal stem cells are produced compared to traditional planar cultures. Its ability to grow at a high surface-to-volume ratio is driving its adoption in the biotechnological space.
The global healthcare sector is undergoing a significant transformation towards regenerative medicine with a view to encountering age-old diseases like Alzheimer’s and spinal cord injuries. Some treatments include cell therapy, gene therapy, and tissue engineering. This is only possible with the regeneration of healthy cells, which are used to replace damaged cells, driving the need for microcarriers to produce a higher number of cells. This is enhancing the research studies on microcarrier production in the market.
To Understand More About this Research: Request a Free Sample Report
- For instance, in 2023, Royal Society Chemistry focused on examining the microcarriers derived from spores and pollens.
Moreover, the growing biotechnology and pharmaceutical industries are positively driving the growth of microcarriers, as they are crucial in various research studies, primarily in cell development and gene therapy. The increasing evolution of cell-based vaccines due to their cost-effectiveness and growing government initiatives to support the healthcare segment are expected to have a positive impact on microcarrier demand in the global market.
However, the higher costs of microcarriers, the lower penetration of skilled personnel in bioprocessing and cell manufacturing, and the emergence of their substitutes, including organoids and 3D cell cultures, are some of the major factors restraining the growth of the market.
The research report offers a quantitative and qualitative analysis of the microcarriers market to enable effective decision-making. It covers the key trends and growth opportunities anticipated to have a favorable impact on the market. Besides, the study covers segment and regional revenue forecasts for market assessment.
Growth Drivers
Rising research activities exploring microcarrier applications
The rising studies on human bodies and cell structures are unraveling the importance of microcarriers. A 2022 study published in the Wiley Biotechnological Journal focused on evaluating the application of layer-by-layer technologies in the surface modification of microcarriers, particularly those used in the manufacturing of human mesenchymal stromal cells. After using the layer-by-layer thin film fabrication method to produce multi-layer collagen microcarriers, they showcased the increased proliferation of cells and harvest amount when it was seeded with human mesenchymal stromal cells.
The rising health issues related to tissue repairs are driving the need for appropriate solutions for tissue regeneration. As the researchers work more on solving human health issues, there will be a need for higher production of therapeutics in the marketplace, in turn driving the need for microcarriers in the world.
The growing concerns about environmental sustainability are emphasizing the creation of plant-based meat and cultured meat in the world. A 2022 study examined the use of edible microcarriers to develop meat alternatives.
The evolution of new ways to approach a problem is rising. For instance, Australia developed a new method for stem cell manufacturing in 2022. As a part of this, they established a 3D printing system for harvesting cells from bioreactors. They used microcarriers for cell proliferation in bioreactors. This signifies that the ongoing developments in the stem cell manufacturing process are supporting the need for microcarriers.
Report Segmentation
The market is primarily segmented based on product, application, therapy, and region.
|
By Product |
By Application |
By Therapy |
By Region |
|
|
|
|
To Understand the Scope of this Report: Speak to Analyst
By Product Analysis
The consumables segment is expected to witness the highest growth during the forecast period.
The consumable segment will grow rapidly, driven by the widespread adoption of microcarriers in cell production processes. The increasing bioprocessing initiatives in the pharmaceutical space are fueling the need for microcarrier beads to produce cells with a higher volume-to-surface ratio in bioreactors.
The equipment segment held a substantial share in 2023, largely attributable to the significant rise in the utilization of single-use bioreactors due to the lower chance of contamination and flexibility.
By Application Analysis
Biopharmaceutical production segment accounted for the largest market share in 2023
The biopharmaceutical production segment accounted for the largest share. The growing establishment of cell-based vaccines on the market is fueling the demand for microcarriers. As an example, a 2023 study examined the alternative to chicken egg influenza vaccine production due to production constraints.
The tissue engineering and regenerative medicine segment is expected to grow at the fastest rate over the next few years on account of the rapid increase in clinical trials to examine regenerative medicine and cell therapies.
By Therapy Analysis
Cell and the gene therapy segment held a significant market revenue share in 2023
The cell and gene therapy segment held a substantial share, which is highly accelerated due to its effectiveness in the production of therapies, as it requires the need to stimulate cell proliferation in suspension. The cost constraints of producing higher therapies are driving the use of microcarriers.
Regional Insights
North America region registered the largest market share in 2023
North America dominated the market. The increasing biotechnological advancements highly influence this in the region. The presence of a strong research base and infrastructure is likely to stimulate the need for microcarriers. Of the world's total of more than 2,000 active clinical programs on cell and gene therapy, 43% of the sites are in North America. The ongoing research activities in this field are creating new opportunities for the market.
The Asia Pacific region will grow rapidly, owing to the continuous rise in investments in the biotechnology and pharmaceutical industries to develop advanced medicines and vaccines in Japan, China, India, and others. As an example, South Korea created a fund of $1.3 billion for the development of cell and gene therapy. This ongoing trend is likely to enhance the demand for microcarriers during the forecast period.
Key Market Players & Competitive Insights
The microcarriers market is slightly fragmented as companies are focusing on catering niche applications and is anticipated to witness competition due to the emergence of new players. Companies are enhancing their investments to promote research activities in developing microcarriers for specified applications. For instance, in September 2022, Carroucell raised €1.5 million to develop advanced microcarriers and adjustable processes for the cell and gene therapy market.
Some of the Major players operating in the global market include:
- Bbi-biotech GmbH
- Bionet
- ChemoMetec
- Corning Incorporated
- Danaher Corporation
- Distek, Inc.
- Entegris
- Eppendorf SE
- Esco Lifesciences Group Ltd
- FUJIFILM Holdings Corporation
- Getinge AB
- Kühner AG
- Lonza
- Merck KGaA
- PBS Biotech, Inc.
Recent Developments
- In October 2023, Semarion introduced an early adopter program for its SemaCyte Microcarrier Platform.
- In June 2022, based on an article published in ScienceDaily, the University of Technology, Sydney, discovered a new method, a 3D printed system, for manufacturing stem cells from bioreactors. This will enable the production of high-quality stem cells at a lower cost in Australia.
Microcarriers Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 1.74 billion |
|
Revenue Forecast in 2032 |
USD 4.11 billion |
|
CAGR |
11.4% from 2024 – 2032 |
|
Base year |
2023 |
|
Historical data |
2019 – 2022 |
|
Forecast period |
2024 – 2032 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2032 |
|
Segments Covered |
By Product, By Application, By Therapy, By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
Delve into the intricacies of microcarriers in 2024 through the meticulously compiled market share, size, and revenue growth rate statistics by Polaris Market Research Industry Reports. Uncover a comprehensive analysis that not only projects market trends up to 2032 but also provides valuable insights into the historical landscape. Immerse yourself in the depth of this industry analysis by acquiring a complimentary PDF download of the sample report.
FAQ's
The Microcarriers Market report covering key segments are product, application, therapy, and region.
Microcarriers Market Size Worth $4.11 Billion By 2032
The global microcarriers market is expected to grow at a CAGR of 11.4% during the forecast period.
North America is leading the global market
key driving factors in Microcarriers Market are rising research activities exploring microcarrier applications
